FR2092714A1 - - Google Patents

Info

Publication number
FR2092714A1
FR2092714A1 FR7021383A FR7021383A FR2092714A1 FR 2092714 A1 FR2092714 A1 FR 2092714A1 FR 7021383 A FR7021383 A FR 7021383A FR 7021383 A FR7021383 A FR 7021383A FR 2092714 A1 FR2092714 A1 FR 2092714A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7021383A
Other languages
French (fr)
Other versions
FR2092714B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melle Bezons SA
Original Assignee
Melle Bezons SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melle Bezons SA filed Critical Melle Bezons SA
Priority to FR7021383A priority Critical patent/FR2092714B1/fr
Priority to ES392093A priority patent/ES392093A1/en
Priority to ES392094A priority patent/ES392094A1/en
Priority to JP4068671A priority patent/JPS504664B1/ja
Priority to GB2760271A priority patent/GB1355718A/en
Priority to DE19712128941 priority patent/DE2128941A1/en
Publication of FR2092714A1 publication Critical patent/FR2092714A1/fr
Application granted granted Critical
Publication of FR2092714B1 publication Critical patent/FR2092714B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FR7021383A 1970-06-11 1970-06-11 Expired FR2092714B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7021383A FR2092714B1 (en) 1970-06-11 1970-06-11
ES392093A ES392093A1 (en) 1970-06-11 1971-06-09 2-amino-5-chloro-thiazole derivatives
ES392094A ES392094A1 (en) 1970-06-11 1971-06-09 2-amino-5-chloro-thiazole derivatives
JP4068671A JPS504664B1 (en) 1970-06-11 1971-06-10
GB2760271A GB1355718A (en) 1970-06-11 1971-06-11 2-amino-5-chloro-thiazole derivatives
DE19712128941 DE2128941A1 (en) 1970-06-11 1971-06-11 New derivatives of the 2 amino 5 chloro thiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7021383A FR2092714B1 (en) 1970-06-11 1970-06-11

Publications (2)

Publication Number Publication Date
FR2092714A1 true FR2092714A1 (en) 1972-01-28
FR2092714B1 FR2092714B1 (en) 1974-03-22

Family

ID=9056998

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7021383A Expired FR2092714B1 (en) 1970-06-11 1970-06-11

Country Status (5)

Country Link
JP (1) JPS504664B1 (en)
DE (1) DE2128941A1 (en)
ES (2) ES392093A1 (en)
FR (1) FR2092714B1 (en)
GB (1) GB1355718A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572074A1 (en) * 1984-10-18 1986-04-25 Sanofi Sa ACTIVE THIADIAZOLE DERIVATIVES ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2612187A1 (en) * 1987-03-12 1988-09-16 Sanofi Sa ACTIVE THIAZOLE DERIVATIVES ON THE CHOLINERGIC SYSTEM, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2618780A1 (en) * 1987-07-29 1989-02-03 Irceba Thiazole derivatives belonging to the 2-piperazinoacetamido-4-methylthiazole family, preparation process and use in therapeutics

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS548367U (en) * 1977-06-20 1979-01-19
JPS5447361U (en) * 1977-09-08 1979-04-02
US4217355A (en) * 1978-04-24 1980-08-12 Pfizer Inc. Amide therapeutic agents
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
CA2503844A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7428A (en) *

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7428A (en) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572074A1 (en) * 1984-10-18 1986-04-25 Sanofi Sa ACTIVE THIADIAZOLE DERIVATIVES ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP0183577A1 (en) * 1984-10-18 1986-06-04 Sanofi Thiadiazole derivatives active on the central nervous system, process for their preparation and pharmaceutical compositions containing them
US4596802A (en) * 1984-10-18 1986-06-24 Sanofi Thiadiazole derivatives active on the central nervous system and pharmaceutical compositions
FR2612187A1 (en) * 1987-03-12 1988-09-16 Sanofi Sa ACTIVE THIAZOLE DERIVATIVES ON THE CHOLINERGIC SYSTEM, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP0283390A2 (en) * 1987-03-12 1988-09-21 Elf Sanofi Thiazole derivatives active on the cholinergic system, process for their preparation and pharmaceutical compositions containing them
EP0283390A3 (en) * 1987-03-12 1988-09-28 Sanofi, Societe Anonyme Thiazole derivatives active on the cholinergic system, process for their preparation and pharmaceutical compositions containing them
FR2618780A1 (en) * 1987-07-29 1989-02-03 Irceba Thiazole derivatives belonging to the 2-piperazinoacetamido-4-methylthiazole family, preparation process and use in therapeutics

Also Published As

Publication number Publication date
FR2092714B1 (en) 1974-03-22
JPS504664B1 (en) 1975-02-22
ES392094A1 (en) 1974-08-01
DE2128941A1 (en) 1971-12-16
ES392093A1 (en) 1974-10-01
GB1355718A (en) 1974-06-05

Similar Documents

Publication Publication Date Title
FR2092714B1 (en)
ATA96471A (en)
AU2044470A (en)
AU2130570A (en)
AU1326870A (en)
AU1716970A (en)
AU1517670A (en)
AU1833270A (en)
AU2017870A (en)
AU1336970A (en)
AU2085370A (en)
AU2144270A (en)
AU1603270A (en)
AU2131570A (en)
ATA672271A (en)
AU2119370A (en)
AU2115870A (en)
AU1328670A (en)
AU2112570A (en)
AU1789870A (en)
AU2061170A (en)
AU1832970A (en)
AU1581370A (en)
AU1974970A (en)
AU1004470A (en)

Legal Events

Date Code Title Description
ST Notification of lapse